Aperiomics

📍 STERLING, United States🗓 Founded 2013👥 20 employees💰 Last funded Dec 2016
Biotechnology🌐 aperiomics.com
Website LinkedIn
Aperiomics is the only company of its kind and scope in the world. We are revolutionizing the way that medical professionals around the world identify infections. Supported by the National Science Foundation, Aperiomics identifies every known bacteria, virus, fungus, and parasite through Deep Shotgun Metagenomic Sequencing, using our world renown database containing over 37,000 microbes. We help doctors and their patients identify the causes of infections that other tests cannot identify, thus streamlining the path to a positive clinical outcome. Many patients that we have helped were sick for years with no understanding of why. Patients and their physicians often contact Aperiomics after hearing about our life-changing success stories. Aperiomics was named Life Science Innovator of the Year in 2016 and International Start Up of the Year in 2018.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2013
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Aperiomics?
Aperiomics has 1 investors on record on gritt.io, 1 mid-stage.
When did Aperiomics last raise funding?
The most recent investment in Aperiomics recorded on gritt.io was in December 2016.
When was Aperiomics founded?
Aperiomics was founded in 2013.
What industry is Aperiomics in?
Aperiomics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Aperiomics based?
Aperiomics is headquartered in STERLING, United States.